Patients with mutations leading to defective beta-oxidation of fatty acid usually have hypoglycemia because of
Less ATP for gluconeogenesis Less acetyl CoA for glucose formation Increased fatty acids decrease glucose utilization Fatty acids inhibit transpo of glucose for metabolism